Cargando…
Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn’s Disease in the Japanese Population
OBJECTIVE: An association between susceptibility to inflammatory bowel disease (IBD) and polymorphisms of both the tyrosine kinase 2 gene (TYK2) and the signal transducer and activator of transcription 3 gene (STAT3) was examined in a Japanese population in order to identify the genetic determinants...
Autores principales: | Sato, Kayoko, Shiota, Mizuho, Fukuda, Sayaka, Iwamoto, Eiko, Machida, Haruhisa, Inamine, Tatsuo, Kondo, Shinji, Yanagihara, Katsunori, Isomoto, Hajime, Mizuta, Yohei, Kohno, Shigeru, Tsukamoto, Kazuhiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788098/ https://www.ncbi.nlm.nih.gov/pubmed/19653082 http://dx.doi.org/10.1007/s10875-009-9320-x |
Ejemplares similares
-
Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease
por: Urabe, Shigetoshi, et al.
Publicado: (2015) -
Polymorphism in autophagy-related genes LRP1 and CAPZA1 may promote gastric mucosal atrophy
por: Yamaguchi, Naoyuki, et al.
Publicado: (2023) -
ATG16L1 and ATG12 Gene Polymorphisms Are Involved in the Progression of Atrophic Gastritis
por: Yamaguchi, Naoyuki, et al.
Publicado: (2023) -
SNP rs2920280 in PSCA Is Associated with Susceptibility to Gastric Mucosal Atrophy and Is a Promising Biomarker in Japanese Individuals with Helicobacter pylori Infection
por: Isomoto, Hajime, et al.
Publicado: (2022) -
Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
por: Takeshima, Fuminao, et al.
Publicado: (2016)